| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 5,350 | 6,900 | 20:33 |
| Stück | Geld | Kurs | Brief | Stück |
|---|---|---|---|---|
| 35,000 | 6 | |||
| 33,000 | 33 | |||
| 15,000 | 15 | |||
| 11,000 | 500 | |||
| 9,500 | 175 | |||
| 6,900 | 1.251 | |||
| 6,350 | 500 | |||
| 6,250 | 75 | |||
| 6,150 | 75 | |||
| 6,050 | 823 | |||
Quelle: [URL] https://aktienkurs-orderbuch.finanznachrichten.de/88q.htm [/URL] | ||||
| 748 | 5,750 | |||
| 75 | 5,700 | |||
| 75 | 5,600 | |||
| 75 | 5,500 | |||
| 1.251 | 5,350 | |||
| 300 | 4,900 | |||
| 700 | 4,740 | |||
| 1.061 | 0,001 | |||
| Summe Aktien im Kauf | Verhältnis | Summe Aktien im Verkauf | ||
| 4.285 | 0,806 | 3.453 | ||
| Uhrzeit | Aktienkurs | Stück |
|---|---|---|
| 11:42:13 | 5,900 | 800 |
| 09:06:32 | 6,000 | 87 |
| Tagesumsatz Xetra | +0,050 +0,86 % | 887 |
Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Genezen to Offer Access to 4basebio Synthetic DNA Platform for Viral Vectors | 11 | Contract Pharma | ||
| 4BASEBIO Aktie jetzt für 0€ handeln | |||||
| Mi | 4basebio shares jump on new marketing tie-up with US-based Genezen | 9 | Alliance News | ||
| Mi | 4basebio and Genezen Enter into Strategic Collaboration to Advance Synthetic, Cell-Free DNA Platforms for Next-Generation Viral Vector Manufacturing | 329 | GlobeNewswire (Europe) | Commercial collaboration combines 4basebio's synthetic DNA technology with Genezen's viral vector development and manufacturing expertise to support gene therapy programs from early development through... ► Artikel lesen | |
| Mi | 4basebio and Genezen Enter into Strategic Collaboration to Advance Synthetic, Cell-Free DNA Platforms for Next-Generation Viral Vector Manufacturing | 241 | PR Newswire | Commercial collaboration combines 4basebio's synthetic DNA technology with Genezen's viral vector development and manufacturing expertise to support gene therapy programs from early development... ► Artikel lesen | |
| Mi | 4basebio Plc - 4basebio Enters into Strategic Collaboration and Marketing Agreement with Genezen to Advance Synthetic, Cell-Free DNA Platforms for Next-Generation Viral Vector Manufacturing | 336 | PR Newswire | 4basebio Plc - 4basebio Enters into Strategic Collaboration and Marketing Agreement with Genezen to Advance Synthetic, Cell-Free DNA Platforms for Next-Generation Viral Vector Manufacturing
PR... ► Artikel lesen |
| Zeit | Aktuelle Nachrichten | Medien | ||
|---|---|---|---|---|
| 17:15 | NanoRepro übernimmt hyped about science komplett und ordnet Geschäft neu | 4investors | NanoRepro übernimmt für 25.000 Euro sämtliche noch von terraplasma gehaltenen Anteile an der hyped about science GmbH und wird damit Alleingesellschafter. Zur Gesellschaft gehört auch die Marke alphabiol... ► Artikel lesen | |
| 18:23 | THX PHARMA: THX Pharma, BBDF and Biocodex Announce Regulatory Submissions for the Phase 3 Clinical Trial of Batten-1 in Juvenile Batten Disease (CLN3) | Actusnews Wire | Lyon, France - Austin, Texas, USA - Gentilly, France - September 1, 2026 - 6:00 p.m. CEST - THX Pharma (Theranexus), an innovative biopharmaceutical company developing treatments for rare neurological... ► Artikel lesen | |
| 17:34 | NanoRepro: Überraschung vor der HV | boersengefluester.de | Kurz vor der Hauptversammlung (HV) am 7. September 2026 lüftet Nanorepro das Rätsel um die seit Mitte Juli so schwache Kursentwicklung. Und es sind keine besonders angenehmen Fakten, die die im Gesundheits-... ► Artikel lesen | |
| 13:36 | Stoke Therapeutics, Inc.: Stoke Therapeutics and Biogen Announce Presentations of Clinical Data from Studies of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC) | Business Wire | -4-year data from the Phase 1/2a open-label extension (OLE) studies support the potential disease-modifying effects of zorevunersen- -Improvements in cognition and behavior sustained through... ► Artikel lesen | |
| 18:06 | ADOCIA Announces Changes in its Board of Directors with the Appointment of a New Director and a Board Observer | Business Wire |
Ekaterina Smirnyagina steps down from the Board of Directors after thirteen years of service
Maureen Deehan co-opted as Director
Suman Shirodkar appointed as Board Observer
Regulatory... ► Artikel lesen |